InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (98 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
98
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Benkowitz Michael, President and Chief Operating Officer. Officer active across 1 company, notably UNITED THERAPEUTICS Corp. In total, 199 disclosures have been logged. Breakdown: 0 buy · 98 sells. Total volume traded: €88.3m. History available since 5 August 2021. The latest transaction was disclosed on 23 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Benkowitz Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations199 total
17,790 sharesCommon StockSEC:0001673232-26-000013:0
9,375 shares@ US$117.760.6% of flowCommon StockSEC:0001673232-26-000011:0
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000010:0
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000009:0
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000008:0
7,875 shares@ US$146.030.6% of flowCommon StockSEC:0001673232-26-000007:0
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000006:0
14,625 shares@ US$117.761.0% of flowCommon StockSEC:0001673232-26-000005:0
14,625 shares@ US$479.50564.1% of flowCommon StockSEC:0001673232-26-000005:1
7,875 shares@ US$146.030.7% of flowCommon StockSEC:0001673232-26-000005:2
7,875 shares@ US$479.50562.2% of flowCommon StockSEC:0001673232-26-000005:3
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-26-000004:0
7,875 shares@ US$146.030.6% of flowCommon StockSEC:0001673232-26-000003:0
14,625 shares@ US$117.761.0% of flowCommon StockSEC:0001673232-25-000018:0
14,625 shares@ US$502.78714.2% of flowCommon StockSEC:0001673232-25-000018:1
7,875 shares@ US$146.030.7% of flowCommon StockSEC:0001673232-25-000018:2
7,875 shares@ US$502.78712.3% of flowCommon StockSEC:0001673232-25-000018:3
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-25-000017:0
14,625 shares@ US$117.760.9% of flowCommon StockSEC:0001673232-25-000016:0
7,875 shares@ US$478.57782.2% of flowCommon StockSEC:0001673232-25-000015:3
14,625 shares@ US$117.761.0% of flowCommon StockSEC:0001673232-25-000015:0
14,625 shares@ US$478.57784.0% of flowCommon StockSEC:0001673232-25-000015:1
7,875 shares@ US$478.57782.2% of flowCommon StockSEC:0001673232-25-000015:2
182 shares@ US$482.6910.1% of flowCommon StockSEC:0001673232-25-000014:14
14,625 shares@ US$117.761.0% of flowCommon StockSEC:0001673232-25-000014:0
25 of 199 declarations
About Benkowitz Michael
BENKOWITZ MICHAEL is President and Chief Operating Officer at UNITED THERAPEUTICS Corp (XNAS). He has 199 filings in total, and across the 199 sampled filings the transactions are entirely sales for a total of EUR 88259599, with data ranging from 2021-08-06 to 2026-03-17. The most frequent transaction nature is Levée d'options.
